Minnesota Oncology Hematology, P.A. — Coon Rapids, Minnesota

Public research footprint of Minnesota Oncology Hematology, P.A., compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Carcinoma, Non-Small-Cell Lung · Non-Small Cell Lung Cancer · Advanced or Metastatic Renal Cell Carcinoma · Clear-cell Metastatic Renal Cell Carcinoma

Recently updated registry entries

NCT07144280 — A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel… (Recruiting)
NCT06003231 — A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2 (Active Not Recruiting)
NCT06758401 — This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Minnesota Oncology Hematology, P.A.?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.